The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; Eisai; Ipsen; MSD; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen
Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240.
 
Stephen Lam Chan
Consulting or Advisory Role - AstraZeneca/MedImmune; MSD Oncology; Novartis
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Merck; Roche/Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Expert Testimony - Novartis
 
Julien Edeline
No Relationships to Disclose
 
Sadahisa Ogasawara
Honoraria - Bayer; Eisai; Lilly
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly; Lilly; Merck
Research Funding - Bayer; Eisai
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
 
Bruno Daniele
Honoraria - AstraZeneca; Bayer; Eisai; Ipsen; Lilly; MSD
Consulting or Advisory Role - Eisai; Incyte; Ipsen; MSD; Sanofi
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Sanofi
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Philippe Merle
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Merck; Roche
Consulting or Advisory Role - Bayer Schering Pharma
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Sirtex Medical
Speakers' Bureau - Bayer; SIRTEX Medical
Travel, Accommodations, Expenses - Bayer
 
Ho-Yeong Lim
No Relationships to Disclose
 
Yee Chao
No Relationships to Disclose
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
Barbara Anne Haber
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Usha Malhotra
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chih-Chin Liu
Employment - Merck; Merck (I)
Stock and Other Ownership Interests - Merck (I)
 
Masatoshi Kudo
Honoraria - Bayer; Eisai; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche; Lilly
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; CSR Pharma; Eisai; Genentech/Roche; IQVIA; MSD; Novartis; Ono Pharmaceutical